Clinical Trial Update: Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of a therapeutic metabolic intervention for hereditary spastic paraplegia SPG5 has completed; no results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Spastic Paraplegia

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Spastic Paraplegia, Hereditary | Phase 2 | Status: COMPLETED